Judge Rules J&J Unit Must Pay $442M in Antitrust Case

Judge rules J&J unit must pay $442M in antitrust case

A federal judge awarded triple damages after a jury found Biosense Webster withheld support to hospitals that bought reprocessed catheters.

#Sezzle Challenges Shopify An Antitrust Lawsuit Aims to Preserve Competition in the Buy Now, Pay Later Marke...

Sezzle Takes Legal Action Against Shopify: An Antitrust Challenge in the E-Commerce Payment Landscape In a bold step signaling a significant confrontation within the fast-evolving e-commerce finance sector, Sezzle Inc. (NASDAQ: SEZL), the Minneapolis-based digital payment platform known for its buy now, pay later (BNPL) services, announced on June 9, 2025, that it has filed a lawsuit against Shopify Inc. This action is taking place in the U.S. D…

J&J Unit $147M Catheter Antitrust Loss Tripled to $442M by California Federal Judge - USA Herald

Johnson & Johnson’s health technology subsidiary, Biosense Webster, has seen its $147 million antitrust trial loss increase to $442 million following a ruling by a federal jury in California. The jury found that Biosense Webster unlawfully stifled competition by conditioning cardiac mapping services on the purchase of its cardiac catheters. The initial verdict in May favored plaintiff Innovative Health, a company licensed by the U.S. Food and Dr…